Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes
Michaela K. Keck, Zhixiang Zuo, Arun Khattri, et al.
Clinical Cancer Research (2014) Vol. 21, Iss. 4, pp. 870-881
Open Access | Times Cited: 353

Showing 1-25 of 353 citing articles:

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert, Barbara Burtness, Ranee Mehra, et al.
The Lancet Oncology (2016) Vol. 17, Iss. 7, pp. 956-965
Closed Access | Times Cited: 1561
The molecular landscape of head and neck cancer
C. René Leemans, Peter J.F. Snijders, Ruud H. Brakenhoff
Nature reviews. Cancer (2018) Vol. 18, Iss. 5, pp. 269-282
Closed Access | Times Cited: 1107
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
Shona Hendry, Roberto Salgado, Thomas Gevaert, et al.
Advances in Anatomic Pathology (2017) Vol. 24, Iss. 6, pp. 311-335
Open Access | Times Cited: 667
The changing therapeutic landscape of head and neck cancer
John D. Cramer, Barbara Burtness, Quynh‐Thu Le, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 11, pp. 669-683
Closed Access | Times Cited: 618
Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J.-P. Machiels, C. René Leemans, Wojciech Golusiński, et al.
Annals of Oncology (2020) Vol. 31, Iss. 11, pp. 1462-1475
Open Access | Times Cited: 578
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Takahiro Tsujikawa, Sushil Kumar, Rohan N. Borkar, et al.
Cell Reports (2017) Vol. 19, Iss. 1, pp. 203-217
Open Access | Times Cited: 534
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Max D. Wellenstein, Karin E. de Visser
Immunity (2018) Vol. 48, Iss. 3, pp. 399-416
Open Access | Times Cited: 508
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments
Benjamin Solomon, Richard J. Young, Danny Rischin
Seminars in Cancer Biology (2018) Vol. 52, pp. 228-240
Closed Access | Times Cited: 388
Human papillomavirus-related oropharyngeal cancer
Miren Taberna, M. Mena, Miguel Ángel Pavón, et al.
Annals of Oncology (2017) Vol. 28, Iss. 10, pp. 2386-2398
Open Access | Times Cited: 358
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
Hui Luo, Qi Zhao, Wei Wei, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 524
Closed Access | Times Cited: 339
–Omic and Electronic Health Record Big Data Analytics for Precision Medicine
Po-Yen Wu, Chih‐Wen Cheng, Chanchala Kaddi, et al.
IEEE Transactions on Biomedical Engineering (2016) Vol. 64, Iss. 2, pp. 263-273
Open Access | Times Cited: 286
Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
Madison Canning, Gang Guo, Miao Yu, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 275
Pan-cancer deconvolution of tumour composition using DNA methylation
Ankur Chakravarthy, Andrew J.S. Furness, Kroopa Joshi, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 274
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
Chen Huang, Lijun Chen, Sara R. Savage, et al.
Cancer Cell (2021) Vol. 39, Iss. 3, pp. 361-379.e16
Open Access | Times Cited: 273
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC
Lillian L. Siu, Caroline Even, Ricard Mesı́a, et al.
JAMA Oncology (2018) Vol. 5, Iss. 2, pp. 195-195
Open Access | Times Cited: 269
A Review of HPV-Related Head and Neck Cancer
Kazuhiro Kobayashi, Kenji Hisamatsu, Natsuko Suzui, et al.
Journal of Clinical Medicine (2018) Vol. 7, Iss. 9, pp. 241-241
Open Access | Times Cited: 260
Translational genomics and recent advances in oral squamous cell carcinoma
Annie Wai Yeeng Chai, Kue Peng Lim, Sok Ching Cheong
Seminars in Cancer Biology (2019) Vol. 61, pp. 71-83
Closed Access | Times Cited: 217
The role of HPV RNA transcription, immune response‐related gene expression and disruptiveTP53mutations in diagnostic and prognostic profiling of head and neck cancer
Gunnar Wichmann, Maciej Rosołowski, Knut Krohn, et al.
International Journal of Cancer (2015) Vol. 137, Iss. 12, pp. 2846-2857
Open Access | Times Cited: 216
Human papillomavirus and the landscape of secondary genetic alterations in oral cancers
Maura L. Gillison, Keiko Akagi, Weihong Xiao, et al.
Genome Research (2018) Vol. 29, Iss. 1, pp. 1-17
Open Access | Times Cited: 210
CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)
Panagiotis Balermpas, Franz Rödel, Claus Rödel, et al.
International Journal of Cancer (2015) Vol. 138, Iss. 1, pp. 171-181
Open Access | Times Cited: 194
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
Areeg Elmusrati, Justin Wang, Cun‐Yu Wang
International Journal of Oral Science (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 189
Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ
Ruth J. Davis, Ellen Moore, Paúl E. Clavijo, et al.
Cancer Research (2017) Vol. 77, Iss. 10, pp. 2607-2619
Open Access | Times Cited: 188
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing
Christine H. Chung, Violeta Beleva Guthrie, David L. Masica, et al.
Annals of Oncology (2015) Vol. 26, Iss. 6, pp. 1216-1223
Open Access | Times Cited: 186
Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
H. Mirghani, Pierre Blanchard
Clinical and Translational Radiation Oncology (2017) Vol. 8, pp. 4-11
Open Access | Times Cited: 172
The Immune Subtypes and Landscape of Squamous Cell Carcinoma
Bailiang Li, Yi Cui, Dhanya K. Nambiar, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 12, pp. 3528-3537
Open Access | Times Cited: 167
Page 1 - Next Page

Scroll to top